Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1971 1
1979 2
1980 10
1981 8
1983 6
1984 13
1985 5
1986 10
1987 15
1988 8
1989 3
1990 14
1991 7
1992 10
1993 5
1994 4
1995 4
1996 5
1997 4
1998 4
1999 3
2000 3
2001 4
2002 3
2004 1
2005 1
2006 3
2007 2
2008 13
2009 6
2010 14
2011 13
2012 14
2013 11
2014 12
2015 15
2016 9
2017 9
2018 5
2019 12
2020 9
2021 7
2022 4
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban for extended treatment of venous thromboembolism.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI; AMPLIFY-EXT Investigators. Agnelli G, et al. N Engl J Med. 2013 Feb 21;368(8):699-708. doi: 10.1056/NEJMoa1207541. Epub 2012 Dec 8. N Engl J Med. 2013. PMID: 23216615 Free article. Clinical Trial.
Oral apixaban for the treatment of acute venous thromboembolism.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators. Agnelli G, et al. N Engl J Med. 2013 Aug 29;369(9):799-808. doi: 10.1056/NEJMoa1302507. Epub 2013 Jul 1. N Engl J Med. 2013. PMID: 23808982 Free article. Clinical Trial.
Oral rivaroxaban for symptomatic venous thromboembolism.
EINSTEIN Investigators; Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S. EINSTEIN Investigators, et al. N Engl J Med. 2010 Dec 23;363(26):2499-510. doi: 10.1056/NEJMoa1007903. Epub 2010 Dec 3. N Engl J Med. 2010. PMID: 21128814 Free article. Clinical Trial.
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.
Ramis-Zaldivar JE, Gonzalez-Farré B, Balagué O, Celis V, Nadeu F, Salmerón-Villalobos J, Andrés M, Martin-Guerrero I, Garrido-Pontnou M, Gaafar A, Suñol M, Bárcena C, Garcia-Bragado F, Andión M, Azorín D, Astigarraga I, Sagaseta de Ilurdoz M, Sábado C, Gallego S, Verdú-Amorós J, Fernandez-Delgado R, Perez V, Tapia G, Mozos A, Torrent M, Solano-Páez P, Rivas-Delgado A, Dlouhy I, Clot G, Enjuanes A, López-Guillermo A, Galera P, Oberley MJ, Maguire A, Ramsower C, Rimsza LM, Quintanilla-Martinez L, Jaffe ES, Campo E, Salaverria I. Ramis-Zaldivar JE, et al. Among authors: garcia bragado f. Blood. 2020 Jan 23;135(4):274-286. doi: 10.1182/blood.2019002699. Blood. 2020. PMID: 31738823 Free PMC article.
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
EINSTEIN–PE Investigators; Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A. EINSTEIN–PE Investigators, et al. N Engl J Med. 2012 Apr 5;366(14):1287-97. doi: 10.1056/NEJMoa1113572. Epub 2012 Mar 26. N Engl J Med. 2012. PMID: 22449293 Free article. Clinical Trial.
Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.
Hokusai-VTE Investigators; Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. Hokusai-VTE Investigators, et al. N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991658 Free article. Clinical Trial.
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.
Bikdeli B, Caraballo C, Trujillo-Santos J, Galanaud JP, di Micco P, Rosa V, Cusidó GV, Schellong S, Mellado M, Del Valle Morales M, Gavín-Sebastián O, Mazzolai L, Krumholz HM, Monreal M; RIETE Investigators. Bikdeli B, et al. JAMA Cardiol. 2022 Aug 1;7(8):857-865. doi: 10.1001/jamacardio.2022.1988. JAMA Cardiol. 2022. PMID: 35830171 Free PMC article.
Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry.
Cohen O, Barg AA, Nowak-Göttl U, Amado-Fernández C, Mazzolai L, Tiberio G, Schellong S, Skride A, Morales MDV, Monreal M, Kenet G; RIETE Investigators. Cohen O, et al. J Thromb Haemost. 2023 Oct;21(10):2811-2823. doi: 10.1016/j.jtha.2023.06.031. Epub 2023 Jul 3. J Thromb Haemost. 2023. PMID: 37406932
Cryoglobulinemia and fibronectin.
Villar M, García-Bragado F, Joven J, Biosca M, Antolin M, Rodrigo MJ, Schwartz S. Villar M, et al. Among authors: garcia bragado f. Acta Haematol. 1985;74(3):161-3. doi: 10.1159/000206197. Acta Haematol. 1985. PMID: 3938159
COVID-19-associated venous thromboembolism: risk of recurrence and major bleeding.
Demelo-Rodriguez P, Alonso-Beato R, Jara-Palomares L, Galeano-Valle F, Bura-Riviere A, Visonà A, Francisco I, Vidal G, López-Ruiz A, Monreal M; RIETE Investigators. Demelo-Rodriguez P, et al. Res Pract Thromb Haemost. 2023 Sep 20;7(7):102206. doi: 10.1016/j.rpth.2023.102206. eCollection 2023 Oct. Res Pract Thromb Haemost. 2023. PMID: 37840687 Free PMC article.
295 results